mug118 Antibody

What is MYH11 and why is it a significant research target?

MYH11, also known as smooth muscle myosin heavy chain, is a critical protein involved in muscle contraction and cellular movement mechanisms. It functions by interacting with actin filaments to generate force, making it essential for various physiological processes including vasoconstriction and gastrointestinal motility. Its central role in smooth muscle function makes MYH11 an important target for studying vascular diseases, gastrointestinal disorders, and other conditions involving smooth muscle dysfunction . Researchers targeting MYH11 can gain insights into fundamental mechanisms of cellular motility and contractile function in both normal and pathological states.

What are the common applications for MYH11 antibodies in research?

MYH11 antibodies are versatile research tools employed across multiple experimental techniques. Based on available data, these antibodies can be used in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), flow cytometry (FCM), and enzyme-linked immunosorbent assays (ELISA) . The diversity of compatible techniques makes MYH11 antibodies valuable for both protein identification and localization studies. Researchers commonly use these antibodies to investigate smooth muscle cell phenotypes, vascular development, and tissue remodeling processes where smooth muscle function plays a crucial role.

What types of MYH11 antibody preparations are available for research?

MYH11 antibodies are available in several preparations to suit various experimental needs. For instance, the MYH11 Mouse anti-Human Clone ID8 is supplied as a purified mouse monoclonal antibody in 10 mM PBS . Other preparations include the MYH11 Antibody (G-4), which is available both non-conjugated and in various conjugated forms including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates . The availability of different conjugates enables researchers to select the appropriate format based on their detection method and experimental design.

What are the critical considerations for western blot applications of MYH11 antibodies?

When employing MYH11 antibodies for western blotting, researchers should be aware of several technical considerations. MYH11 is a high molecular weight protein (approximately 200-250 kDa), requiring appropriate gel concentration and transfer conditions. Extended transfer times or specialized transfer buffers may be necessary for complete transfer of this large protein. Blocking solutions should be optimized to reduce background while maintaining specific signal. When selecting positive controls, tissues with high smooth muscle content (such as uterus or vascular tissue) are recommended . Researchers should also be prepared to optimize exposure times, as the signal intensity may vary depending on MYH11 expression levels in different sample types.

What storage and handling protocols maximize MYH11 antibody stability and performance?

To maintain optimal activity of MYH11 antibodies, proper storage and handling are essential. The MYH11 Mouse anti-Human antibody should be stored at temperatures between -20°C and -80°C . Aliquoting the antibody upon receipt is recommended to avoid repeated freeze-thaw cycles, which can degrade antibody quality and reduce binding efficiency. Working dilutions should be prepared fresh before use and stored at appropriate temperatures according to manufacturer recommendations. Prior to use, antibody solutions should be centrifuged briefly to collect contents at the bottom of the tube and ensure proper mixing. Following these handling protocols helps maintain antibody specificity and sensitivity across experiments.

How can MYH11 antibody specificity be validated in experimental systems?

Validating antibody specificity is critical for ensuring reliable research outcomes. For MYH11 antibodies, multiple validation approaches should be employed. First, researchers should perform western blot analysis to confirm that the antibody detects a protein of the expected molecular weight. Second, comparative analysis using multiple antibodies targeting different epitopes of MYH11 can provide confirmation of specificity. Third, researchers can use knockout/knockdown models where MYH11 expression is eliminated or reduced as negative controls. Fourth, immunoprecipitation followed by mass spectrometry can verify that the antibody is capturing the intended target. Finally, immunofluorescence co-localization studies with other smooth muscle markers can provide functional validation of specificity . This multi-faceted approach ensures that experimental results are truly reflective of MYH11 biology.

How does MYH11 antibody perform in multi-color flow cytometry experiments?

For flow cytometry applications, researchers need to consider several aspects of experimental design when using MYH11 antibodies. The MYH11 antibody can be used at a concentration of 0.5-1 μg per 10^6 cells in 0.1 mL for flow cytometry . When designing multi-color panels, researchers should consider the spectral properties of conjugated MYH11 antibodies to avoid fluorescence overlap. Since MYH11 is primarily an intracellular protein, appropriate permeabilization protocols must be employed, such as methanol or saponin-based methods. Compensation controls are essential when using multiple fluorophores, and titration experiments should be performed to determine optimal antibody concentrations that maximize signal-to-noise ratios. Dead cell discrimination dyes are also recommended to eliminate false positives from non-specific binding to dead cells.

How should researchers design experiments to study MYH11's role in smooth muscle function?

When designing experiments to investigate MYH11's role in smooth muscle function, researchers should consider a comprehensive approach. Begin with expression analysis using MYH11 antibodies in immunohistochemistry or western blotting to establish baseline expression in tissues of interest . For functional studies, combine MYH11 localization with measurements of contractile responses in tissue or cell models. Co-immunoprecipitation experiments can identify MYH11 interaction partners in the contractile apparatus. For in vivo studies, consider tissue-specific conditional knockout models to avoid the embryonic lethality associated with complete MYH11 deficiency. Time-course experiments during development or disease progression can reveal dynamic changes in MYH11 expression and function. The experimental design should incorporate appropriate controls, including both positive controls (tissues known to express MYH11) and negative controls (tissues with minimal MYH11 expression or where the primary antibody is omitted).

What are common pitfalls in MYH11 antibody-based experiments and how can they be addressed?

Addressing these common challenges requires systematic optimization and rigorous controls to ensure reliable and reproducible results when working with MYH11 antibodies .

How can researchers integrate MYH11 antibody data with other molecular approaches for comprehensive analysis?

For comprehensive analysis of MYH11 biology, researchers should integrate antibody-based data with complementary molecular approaches. Begin by establishing MYH11 protein expression patterns using immunological methods, then correlate these with mRNA expression data from RT-PCR or RNA-seq to identify potential post-transcriptional regulation. Chromatin immunoprecipitation (ChIP) can reveal transcription factors regulating MYH11 expression. Functional studies using siRNA or CRISPR-based knockdown/knockout approaches can validate findings from antibody-based observations. Live-cell imaging with fluorescently tagged MYH11 can provide dynamic information about protein localization and movement. Computational approaches, including pathway analysis and protein-protein interaction networks, can place MYH11 findings in broader biological context. This multi-modal approach provides robust validation across different techniques and offers deeper insights into MYH11 biology than any single method alone.

How does MYH11 antibody application differ from similar antibodies like MUC1 in research contexts?

While both MYH11 and MUC1 antibodies are valuable research tools, they target proteins with distinct biological functions and experimental applications. MYH11 antibodies target smooth muscle myosin heavy chain, a contractile protein essential for muscle function , whereas MUC1 antibodies recognize a membrane-bound glycoprotein overexpressed in adenocarcinomas . In research applications, MYH11 antibodies are primarily used to study smooth muscle physiology, vascular development, and related pathologies. In contrast, MUC1 antibodies have significant applications in cancer research, particularly breast cancer, where MUC1 overexpression correlates with prognosis . From a methodological perspective, MYH11 antibodies typically require permeabilization for intracellular staining, while MUC1 antibodies can detect cell surface epitopes without permeabilization. Understanding these distinctions helps researchers select the appropriate antibody for their specific research questions.

What considerations are important when studying MYH11 in different tissue contexts?

The application of MYH11 antibodies across different tissue contexts requires tissue-specific considerations. In vascular tissues, MYH11 expression varies between arteries, veins, and capillaries, necessitating careful interpretation of staining patterns. In gastrointestinal tissues, MYH11 expression differs between circular and longitudinal muscle layers, requiring precise anatomical orientation during sectioning. During development or in pathological states, MYH11 expression patterns may change dramatically, necessitating time-course studies. Some tissues may express MYH11 isoforms preferentially, potentially affecting antibody binding depending on the epitope recognized. Background autofluorescence varies significantly between tissues (particularly in elastic vessels), requiring appropriate controls and potentially different detection methods. Researchers should optimize fixation protocols for each tissue type, as overfixation can mask MYH11 epitopes to different degrees depending on tissue composition .

How can genetic factors influence MYH11 antibody-based research outcomes?

Genetic factors can significantly impact MYH11 antibody-based research outcomes in several ways. First, genetic variations in MYH11 may alter epitope sequences recognized by antibodies, potentially affecting binding efficiency in different populations or disease states. Second, alternative splicing of MYH11 generates multiple isoforms with tissue-specific expression patterns, requiring careful antibody selection to detect all relevant isoforms or specific variants. Third, genetic modifiers can influence MYH11 expression levels, necessitating quantitative approaches beyond simple presence/absence detection. This principle is illustrated by research on MUC1, where immunoglobulin GM (γ marker), KM (κ marker), and Fcγ receptor genotypes were found to influence antibody responsiveness in a racially restricted manner . By considering genetic influences, researchers can better account for variability in their results and potentially identify subpopulations with distinct MYH11 characteristics.